Application of the revised International Prognostic Scoring System for myelodysplastic syndromes in 470 Argentinean patients

被引:0
|
作者
Belli, C. [1 ]
Bestach, Y. [2 ]
Bengio, R. [3 ]
Sakamoto, F. [4 ]
Nucifora, E. [5 ]
Gonzalez, J. [6 ]
Crisp, R. [7 ]
Fazio, P. [8 ]
Pintos, N. [9 ]
Larripa, I. [10 ]
机构
[1] Consejo Nacl Invest Cient & Tecn, Acad Nacl Med Grp Estudio SMD, IMEX, Genet Hematol, RA-1033 Buenos Aires, DF, Argentina
[2] Consejo Nacl Invest Cient & Tecn, Acad Nacl Med, IMEX, Genet Hematol, RA-1033 Buenos Aires, DF, Argentina
[3] IIHEMA ANM, Med Clin, Buenos Aires, DF, Argentina
[4] Privado Hematol & Hemoterapia, Hematol, Parana, Argentina
[5] Hosp Italiano Buenos Aires, Grp Estudio SMD, Hematol, Buenos Aires, DF, Argentina
[6] HIGA C Durand Grp Estudio SMD, Hematol, Buenos Aires, DF, Argentina
[7] Hosp A Posadas Grp Estudio SMD, Hematol, El Palomar, Argentina
[8] HIGA San Martin Grp Estudio SMD, Hematol, La Plata, Argentina
[9] Sanatorio Julio Mendez Grp Estudio SMD, Hematol, Buenos Aires, DF, Argentina
[10] Consejo Nacl Invest Cient & Tecn, Acad Nacl Med, IMEX, Genet Hematol, RA-1033 Buenos Aires, DF, Argentina
关键词
D O I
10.1016/S0145-2126(13)70156-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-108
引用
收藏
页码:S71 / S72
页数:2
相关论文
共 50 条
  • [21] Validation of the Revised International Prognostic Scoring System (R-IPSS) for Patients with Myelodysplastic Syndromes: Therapeutic Implications.
    Mishra, Asmita
    Al Ali, Najla H.
    Corrales-Yepez, Maria
    Padron, Eric
    Zhang, Ling
    Epling-Burnette, Pearlie K.
    Kharfan-Dabaja, Mohamed A.
    Pinilla-Ibarz, Javier
    Little, Bryan J.
    Lancet, Jeffrey E.
    List, Alan F.
    Komrokji, Rami S.
    BLOOD, 2012, 120 (21)
  • [22] The Revised International Prognostic Scoring System (IPSS-R) Is Not Predictive Of Survival In Patients With Secondary Myelodysplastic Syndromes (MDS)
    Nazha, Aziz
    Mukherjee, Sudipto
    Tiu, Ramon V.
    Saunthararajah, Yogen
    Keng, Michael K.
    Seastone, David J.
    Hobson, Sean
    Advani, Anjali S.
    Maciejewski, Jaroslaw P.
    Sekeres, Mikkael A.
    BLOOD, 2013, 122 (21)
  • [23] Impact of clone size with a single cytogenetic abnormality on the revised International Prognostic Scoring System in myelodysplastic syndromes
    Alkharabsheh, Omar
    Saadeh, Salwa S.
    Patnaik, Mrinal S.
    Alkhateeb, Hassan
    Gangat, Naseema
    Begna, Kebede H.
    Hogan, William J.
    Greipp, Patricia T.
    He, Rong
    Nguyen, Phuong L.
    Litzow, Mark R.
    Al-Kali, Aref
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (12) : E398 - E401
  • [24] Improved risk stratification by the integration of the revised International Prognostic Scoring System with the Myelodysplastic Syndromes Comorbidity Index
    van Spronsen, M. F.
    Ossenkoppele, G. J.
    Holman, R.
    van de Loosdrecht, A. A.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (18) : 3198 - 3205
  • [25] Application of the International Prognostic Scoring System-Revised in therapy-related myelodysplastic syndromes and oligoblastic acute myeloid leukemia
    Ok, C. Y.
    Hasserjian, R. P.
    Fox, P. S.
    Stingo, F.
    Zuo, Z.
    Young, K. H.
    Patel, K.
    Medeiros, L. J.
    Garcia-Manero, G.
    Wang, S. A.
    LEUKEMIA, 2014, 28 (01) : 185 - 189
  • [26] Application of the International Prognostic Scoring System-Revised in therapy-related myelodysplastic syndromes and oligoblastic acute myeloid leukemia
    C Y Ok
    R P Hasserjian
    P S Fox
    F Stingo
    Z Zuo
    K H Young
    K Patel
    L J Medeiros
    G Garcia-Manero
    S A Wang
    Leukemia, 2014, 28 : 185 - 189
  • [27] International prognostic scoring system and other prognostic systems for myelodysplastic syndromes - Response
    Greenberg, P
    Cox, C
    Bennett, J
    BLOOD, 1997, 90 (10) : 4233 - 4234
  • [28] Validation and improvement of the molecular international prognostic scoring system in Chinese patients with myelodysplastic syndromes
    Nanfang Huang
    Yang Song
    Lingyun Wu
    Qi He
    Zheng Zhang
    Juan Guo
    Feng Xu
    Chunkang Chang
    Xiao Li
    Annals of Hematology, 2025, 104 (1) : 193 - 206
  • [29] Prognostic Value of Circulating Myeloblasts in Patients with Myelodysplastic Syndromes (MDS): A Proposal for Incorporation in the Revised International Prognostic Scoring System (R-IPSS)
    Komrokji, Rami S.
    Padron, Eric
    Al Ali, Najla H.
    Lancet, Jeffrey E.
    Hall, Jeff
    Kwok, Brian
    Zhang, Ling
    Epling-Burnette, Pearlie K.
    List, Alan F.
    BLOOD, 2014, 124 (21)
  • [30] Report on outcomes of hypomethylating therapy for analyzing prognostic value of Revised International Prognostic Scoring System for patients with lower-risk myelodysplastic syndromes
    Yoo Jin Lee
    Sung Woo Park
    In Hee Lee
    Jae Sook Ahn
    Hyeoung Joon Kim
    Joo Seop Chung
    Ho Jin Shin
    Won Sik Lee
    Sang Min Lee
    Young Don Joo
    Hawk Kim
    Ho Sup Lee
    Yang Soo Kim
    Yoon Young Cho
    Joon Ho Moon
    Sang Kyun Sohn
    Annals of Hematology, 2016, 95 : 1795 - 1804